Home > News > World
Monday August 25, 2014 MYT 11:45:03 AM
Monday August 25, 2014 MYT 11:46:18 AM
TOKYO (Reuters) - Japan could offer an unapproved drug under certain circumstances to help treat the deadly Ebola virus even before the World Health Organization has decided to make a request for the drug, the country's top government spokesman said on Monday.
Chief Cabinet Secretary Yoshihide Suga told a news conference that Japan would cooperate with the WHO and was ready to make an international contribution.
"I am informed that medical professionals could make a request for T-705 in an emergency even before a decision by the WHO. In that case, we would like to respond under certain criteria," he said.
T-705 is the developmental code for the influenza drug favipiravir. Japan's Fujifilm Holdings Corp and U.S. partner MediVector are in talks with the U.S. Food and Drug Administration to submit an application to expand the use of favipiravir as a treatment for Ebola.
The Ebola epidemic in West Africa has killed more than 1,000 people and prompted the WHO to declare an international health emergency.
(Reporting by Kaori Kaneko; Editing by Chris Gallagher)
Finland doubles asylum seeker forecast to 30,000
U.N. demands Europe mobilise on migrants, Hungary warns of 'mass inflow'
Drowned Syrian toddlers and their mother buried in Kobani
Russia says Syria's Assad ready to share power
Head of U.N.'s refugee agency to step down this year
TalentCorp turns Malaysia’s brain drain to brain gain
Carnival visitors enjoy the best hawker fare Penang has to offer
Fun-filled Matta fair awaits visitors
Shooter Lutfi relieved to regain form after a lean spell
Copyright © 1995-2015 Star Media Group Berhad (ROC 10894D)(Formerly known as Star Publications (Malaysia) Berhad)